LINCOLNSHIRE, Ill., June 9 /PRNewswire-FirstCall/ -- Aksys®, Ltd. (Nasdaq: AKSY - News), a pioneer in innovative dialysis systems, today announced that it expects to file on or about June 12, 2006 with the Securities and Exchange Commission a Schedule 14f-1 regarding its planned change in the majority of the directors on its board. The board changes will become effective at the closing of the securities purchase agreement previously entered into by Aksys and Durus Life Sciences Master Fund, Ltd., which is anticipated to occur on or about June 23, 2006.
